This finding suggests that insulin action in the brain may be clinically relevant in the treatment of individuals who are obese and diabetic and mandates further research to fully understand the mechanisms of brain insulin signalling in animal models of obesity and diabetes. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.